Skip to content

Discontinued — last reported Q4 '25

Geographic · Segment Assets

Corporate Items — Segment Assets

Zimmer Biomet Holdings Corporate Items — Segment Assets decreased by 15.2% to $1.35B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 3.7%, from $1.41B to $1.35B.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2022
Last reportedQ4 2025Feb 20, 2026

How to read this metric

An increase suggests a buildup of cash or corporate-level investments, whereas a decrease may indicate asset divestitures or the reallocation of capital to specific operating segments.

Detailed definition

This metric captures the total value of assets held at the corporate level that are not directly attributable to specifi...

Peer comparison

Large-cap medical device companies often maintain significant corporate assets to support global R&D and M&A activities, making this a standard line item for overhead analysis.

Metric ID: zbh_segment_corporate_items_segment_assets

Historical Data

7 periods
 Q4 '22Q4 '23Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$1.34B$1.58B$1.41B$1.4B$1.6B$1.6B$1.35B
QoQ Change+17.8%-11.1%-0.1%+14.2%-0.5%-15.2%
YoY Change+17.8%-11.1%-3.7%
Range$1.34B$1.6B
CAGR+0.6%
Avg YoY Growth+1.0%
Median YoY Growth-3.7%
Current Streak2 quarters decline

Frequently Asked Questions

What is Zimmer Biomet Holdings's corporate items — segment assets?
Zimmer Biomet Holdings (ZBH) reported corporate items — segment assets of $1.35B in Q4 2025.
How has Zimmer Biomet Holdings's corporate items — segment assets changed year-over-year?
Zimmer Biomet Holdings's corporate items — segment assets decreased by 3.7% year-over-year, from $1.41B to $1.35B.
What does corporate items — segment assets mean?
The total value of assets held at the corporate level that are not assigned to specific business segments.